In vitro activity of essential oils on microorganisms isolated from vaginal infections

International Journal of Aromatherapy

Volumn 16, Issue 3-4, 2006, Pages 169-174

  Schwiertz, A ^a   Duttke, C ^a   Hild, J ^a,b   Muller H J ^b  

^a Institute for Microecology   (Germany)

^b TECHNISCHE HOCHSCHULE MITTELHESSEN   (Germany)

Author keywords

Essential oils; Vaginal infection

Indexed keywords

ESSENTIAL OIL; LAVENDER OIL; TEA TREE OIL;

ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ARTICLE; BACTERICIDAL ACTIVITY; BACTEROIDES VULGATUS; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CONTROLLED STUDY; CYMBOPOGON CITRATUS; DRUG POTENCY; GARDNERELLA VAGINALIS; GERANIUM; LACTOBACILLUS; LAVENDER; MICROORGANISM; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; ROSEMARY; STREPTOCOCCUS AGALACTIAE; THYME; VAGINITIS;

EID: 33751420616     PISSN: 09624562     EISSN: 14769409     Source Type: Journal    
DOI: 10.1016/j.ijat.2006.09.005     Document Type: Article

References (42)

1. Adams R.P. Identification of essential oils components by gas chromatography/mass spectroscopy (1995), Allured Publ Corp, Carol Stream, IL
2. Azaz A.D., Irtem H.A., Kurkcuoglu M., and Baser K.H. Composition and the in vitro antimicrobial activities of the essential oils of some Thymus species. Z Naturforsch [C] 59 (2004) 75-80
3. Banes-Marshall L., Cawley P., and Phillips C.A. In vitro activity of Melaleuca alternifolia (tea tree) oil against bacterial and Candida spp. isolates from clinical specimens. Br J Biomed Sci 58 (2001) 139-145
4. Burton J.P., Devillard E., Cadieux P.A., Hammond J.A., and Reid G. Detection of Atopobium vaginae in postmenopausal women by cultivation-independent methods warrants further investigation. J Clin Microbiol 42 (2004) 1829-1831
5. Demirci F., Iscan G., Guven K., Kirimer N., Demirci B., and Baser K.H. Antimicrobial activities of Ferulago essential oils. Z Naturforsch [C] 55 (2000) 886-889
6. Ergin A., and Arikan S. Comparison of microdilution and disc diffusion methods in assessing the in vitro activity of fluconazole and Melaleuca alternifolia (tea tree) oil against vaginal Candida isolates. J Chemother 14 (2002) 465-472
7. Eschenbach D.A. Vaginitis including bacterial vaginosis. Curr Opin Obstet Gynecol 6 (1994) 389-391
8. Eschenbach D.A., Davick P.R., Williams B.L., et al. Prevalence of hydrogen peroxide-producing Lactobacillus species in normal women and women with bacterial vaginosis. J Clin Microbiol 27 (1989) 251-256
9. Ferrer J. Vaginal candidosis: epidemiological and etiological factors. Int J Gynaecol Obstet 71 Suppl. 1 (2000) S21-S27
10. Ferris M.J., Masztal A., Aldridge K.E., Fortenberry J.D., Fidel Jr. P.L., and Martin D.H. Association of Atopobium vaginae, a recently described metronidazole resistant anaerobe, with bacterial vaginosis. BMC Infect Dis 4 (2004) 5
11. Filipowicz N., Kaminski M., Kurlenda J., Asztemborska M., and Ochocka J.R. Antibacterial and antifungal activity of juniper berry oil and its selected components. Phytother Res 17 (2003) 227-231
12. Garland S.M., Ni C.F., Satzke C., and Robins-Browne R. Mechanisms, organisms and markers of infection in pregnancy. J Reprod Immunol 57 (2002) 169-183
13. Gonzalez Pedraza A.A., Ortiz Zaragoza M.C., and Irigoyen C.A. Bacterial vaginosis a "broad overview". Rev Latinoam Microbiol 41 (1999) 25-34
14. Hammer K.A., Carson C.F., and Riley T.V. In vitro activity of essential oils, in particular Melaleuca alternifolia (tea tree) oil and tea tree oil products, against Candida spp. J Antimicrob Chemother 42 (1998) 591-595
15. Hammer K.A., Carson C.F., and Riley T.V. Antimicrobial activity of essential oils and other plant extracts. J Appl Microbiol 86 (1999) 985-990
16. Hammer K.A., Carson C.F., and Riley T.V. In vitro susceptibilities of lactobacilli and organisms associated with bacterial vaginosis to Melaleuca alternifolia (tea tree) oil. Antimicrob Agents Chemother 43 (1999) 196
17. Hammer K.A., Dry L., Johnson M., Michalak E.M., Carson C.F., and Riley T.V. Susceptibility of oral bacteria to Melaleuca alternifolia (tea tree) oil in vitro. Oral Microbiol Immunol 18 (2003) 389-392
18. 2-producing lactobacilli, and bacterial vaginosis in pregnant women. Clin Infect Dis 16 Suppl. 4 (1993) S273-S281
19. Holland J., Young M.L., Lee O., and Chen A. Vulvovaginal carriage of yeasts other than Candida albicans. Sex Trans Infect 79 (2003) 249-250
20. Inouye S., Takizawa T., and Yamaguchi H. Antibacterial activity of essential oils and their major constituents against respiratory tract pathogens by gaseous contact. J Antimicrob Chemother 47 (2001) 565-573
21. Inouye S., Yamaguchi H., and Takizawa T. Screening of the antibacterial effects of a variety of essential oils on respiratory tract pathogens, using a modified dilution assay method. J Infect Chemother 7 (2001) 251-254
22. Joesoef M.R., Schmid G.P., and Hillier S.L. Bacterial vaginosis: review of treatment options and potential clinical indications for therapy. Clin Infect Dis 28 Suppl. 1 (1999) S57-S65
23. Kalemba D., and Kunicka A. Antibacterial and antifungal properties of essential oils. Curr Med Chem 10 (2003) 813-829
24. Katz V.L. Management of group B streptococcal disease in pregnancy. Clin Obstet Gynecol 36 (1993) 832-842
25. Manohar V., Ingram C., Gray J., et al. Antifungal activities of origanum oil against Candida albicans. Mol Cell Biochem 228 (2001) 111-117
26. Mondello F., De Bernardis F., Girolamo A., Salvatore G., and Cassone A. In vitro and in vivo activity of tea tree oil against azole-susceptible and -resistant human pathogenic yeasts. J Antimicrob Chemother 51 (2003) 1223-1229
27. Quan M. Vaginitis: meeting the clinical challenge. Clin Cornerstone 3 (2000) 36-47
28. Setzer W.N., Vogler B., Schmidt J.M., Leahy J.G., and Rives R. Antimicrobial activity of Artemisia douglasiana leaf essential oil. Fitoterapia 75 (2004) 192-200
29. Shennan A., Crawshaw S., Briley A., et al. A randomised controlled trial of metronidazole for the prevention of preterm birth in women positive for cervicovaginal fetal fibronectin: the PREMET Study. BJOG 113 (2006) 65-74
30. Singh S., Sobel J.D., Bhargava P., Boikov D., and Vazquez J.A. Vaginitis due to Candida krusei: epidemiology, clinical aspects, and therapy. Clin Infect Dis 35 (2002) 1066-1070
31. Sobel J.D. Vaginitis. N Engl J Med 337 (1997) 1896-1903
32. Sobel J.D. Treatment of vaginal Candida infections. Expert Opin Pharmacother 3 (2002) 1059-1065
33. Sobel J.D., Chaim W., Nagappan V., and Leaman D. Treatment of vaginitis caused by Candida glabrata: use of topical boric acid and flucytosine. Am J Obstet Gynecol 189 (2003) 1297-1300
34. Spiegel C.A., Amsel R., Eschenbach D., Schoenknecht F., and Holmes K.K. Anaerobic bacteria in nonspecific vaginitis. N Engl J Med 303 (1980) 601-607
35. Spiegel C.A., Davick P., Totten P.A., et al. Gardnerella vaginalis and anaerobic bacteria in the etiology of bacterial (nonspecific) vaginosis. Scand J Infect Dis Suppl 40 (1983) 41-46
36. Sutton D.A., Fothergill A.W., and Rinaldi M.G. Guide to clinically significant fungi (1998), Williams & Wilkins, Baltimore
37. Syed T.S., and Braverman P.K. Vaginitis in adolescents. Adolesc Med Clin 15 (2004) 235-251
38. Takarada K., Kimizuka R., Takahashi N., Honma K., Okuda K., and Kato T. A comparison of the antibacterial efficacies of essential oils against oral pathogens. Oral Microbiol Immunol 19 (2004) 61-64
39. Verhelst R., Verstraelen H., Claeys G., et al. Cloning of 16S rRNA genes amplified from normal and disturbed vaginal microflora suggests a strong association between Atopobium vaginae, Gardnerella vaginalis and bacterial vaginosis. BMC Microbiol 4 (2004) 16
40. Verstraelen H., Verhelst R., Claeys G., Temmerman M., and Vaneechoutte M. Culture-independent analysis of vaginal microflora: the unrecognized association of Atopobium vaginae with bacterial vaginosis. Am J Obstet Gynecol 191 (2004) 1130-1132
41. Xu J., Boyd C.M., Livingston E., Meyer W., Madden J.F., and Mitchell T.G. Species and genotypic diversities and similarities of pathogenic yeasts colonizing women. J Clin Microbiol 37 (1999) 3835-3843
42. Zgoda J.R., and Porter J.R. A convenient microdilution method for screening natural products against bacteria and fungi. Pharm Microbiol 39 (2001) 221-225